| ²é¿´: 754 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
szxxckľ³æ (ÕýʽдÊÖ)
|
[½»Á÷]
ÖØ½ðÇóÖú¸ßÈË·ÒëÒ»¶ÎÕªÒª£¨·ÇGoogle»ò·ÒëÈí¼þ·Ò룩
|
||
|
±¾ÎĺϳÉÁËһϵÁÐÑôÀë×Ó·ú±íÃæ»îÐÔ¼Á, N-[3-(¶þ¼×»ù°·»ù)±û»ù]È«·úÍé»ù»Çõ£°·ÑÎËáÑÎ(CnF2n+1SO2NH(CH2)3NH(CH3)2+Cl¨C, n = 6, 8, ·Ö±ð¼ò³ÆÎªPFH-MCºÍPFO-MC), ²¢ÓõÎÌå»ý·¨²â¶¨25 ◦C¡¢pH 2.6~2.7ʱ¸ÃÀàÎïÖʵĵ¥Ìåϵ¼°¼ÓÑκó([NaCl] = 0.1 mol•L-1)µÄ±íÃæÕÅÁ¦ÇúÏß¡£½áºÏÉÏÊöPFB-MCµÄ½á¹ûÌÖÂÛ·Ö×ӽṹÖÐ̼·úƬ¶ÏµÄÁ´³¤¶ÔË®ÈÜÒºÖбíÃæ»îÐÔµÄÓ°Ïì¡£¶Ô±È½ºÍÅÐγÉÄÜÁ¦¡¢½µµÍ±íÃæÕÅÁ¦µÄÄÜÁ¦¡¢±íÃæÎü¸½×´¿öºÍËáÐÔÌõ¼þµÄÇ¿ÈõÓ°Ïì±íÃæ»îÐÔ¼ÁÊÊÓÃÇé¿öµÄ½á¹û±íÃ÷ÒÔϽáÂÛ¡£Ê×ÏÈ£¬Ëæ×ÅÁ´³¤µÄÔö¼ÓÁÙ½ç½ºÊøÅ¨¶È(cmc)¼õСµ«±íÃæÎü¸½Á¿½µµÍ(µ¥·Ö×ÓÎü¸½Ãæ»ýÔö´ó)£»µ¥Ìåϵ×îµÍ±íÃæÕÅÁ¦(¦Ãcmc)PFH-MC×îС(15.02 mN•m-1)£¬PFO-MCµÄ¦ÃcmcºÍPFH-MCÏà±ÈÂÔÓÐÉÏÉý¿ÉÀí½âΪ³¤Á´±íÃæ»îÐÔ¼ÁµÄÈܽâÐÔµÄÏÞÖÆ»òÕ߿ռäÅÅÁеÄÓ°Ïì¡£Íâ¼ÓÑÎÄܽµµÍÌåϵµÄcmc£¨Õâ¿ÉÒÔͨ¹ýÔö¼Ó̼Á´µÄÊèÈܼÁÐÔÖÊÀ´½âÊÍ£©µ«ÓÉÓÚÑÎËá¹ýÁ¿ÈÜÒºÖÐÏ൱ÓÚÒѾ´æÔÚÒ»¶¨Á¿µÄµç½âÖÊÀ´ÆÁ±ÎÍ·»ùµçºÉµÄÅų⵼Ö¶ԦÃcmcδ¹Û²ìµ½Ó°Ïì¡£ÌÖÂÛÁËÁ´³¤±ä»¯¶ÔÑÎЧӦµÄÓ°Ï죬ÕâÖÖÓ°Ïì³ÊÏÖ²»¹æÔòµÄ±ä»¯£¬PFH-MCËùÊܵÄÑÎЧӦ´ÓijÖ̶ֳȱíÏÖ×îÃ÷ÏÔ¡£Õâ¿ÉÄÜÊÇÓÉÓÚ̼Á´³¤¶ÈPFH-MC×îÊÊÖУ¬¶øPFO-MCºÍPFB-MC¹ý³¤¡¢¹ý¶ÌµÄ̼Á´¼´ÊèË®ÐԽϴó»ò½ÏС¶¼Ê¹µÃÍâ¼ÓNaCl´øÀ´µÄÊèÈܼÁЧӦ¼õС¡£Ñо¿Á˱íÃæ»îÐÔ¼ÁÔÚcmcǰºóµÄ±íÃæÕÅÁ¦ËæpHµÄ±ä»¯¡£ ±¾ÎÄÑо¿Ö¤Ã÷Á˸ÃϵÁÐÒÔÈ«·úÍé»ùΪ»ù´¡µÄ¡¢º¬ÓÐ̼ÇâÆ¬¶ÎµÄÑôÀë×ÓÐÍ·ú±íÃæ»îÐÔ¼ÁÊÊÓÃÓÚÇ¿ËáÐÔ»·¾³¡¢¿¹ÑΡ¢ÇÒ¾ßÓм«¸ßµÄ±íÃæ»îÐÔ£¬ÎÒÃǶÔʵ¼ÊÑ¡Ôñ½øÐÐÁË×ÛºÏÆÀ¼Û£º¸ÃÀà±íÃæ»îÐÔ¼ÁÊÊÓÃÓÚÇ¿ËáÐÔ»·¾³²¢ÇÒ²»Ò×ÊÜÑζȻ·¾³µÄ¸ÉÈÅ¡£¼ÓÑλ¹ÄÜÃ÷ÏÔ¸ÄÉÆ±íÃæ»îÐÔ¼ÁµÄÐÔÄÜ¡¢½µµÍ¸Ã±íÃæ»îÐÔ¼ÁµÄcmc¡£×ÛºÏÆÀ¶¨Á´³¤µÄÓ°Ïì¿ÉÖª£¬¸ù¾ÝʹÓÃÇé¿ö²»Í¬£¬Èç¹û¶Ô³¬µÍ±íÃæÕÅÁ¦ÒªÇóÑϸñ£¬¿ÉÑ¡Ó÷ú̼ÊýΪ6µÄPFH-MC(×îµÍ±íÃæÕÅÁ¦ÏÔÖøµÍÓÚPFB-MC)£¬ËüÎÞÂÛ´ÓŨ¶È(cmcºÍPFO-MCÏà²î²»ÊÇÌØ±ð´ó£¬Ê¹ÓÃʱËùÐèÁ¿Ð¡)»¹ÊÇʹÓõÄÐÔ¼Û±È(̼·úÁ´¶Ì£¬Éú²ú³É±¾ÓÅÓÚPFO-MC)¿¼ÂǶ¼ÊÇÓÅ»¯µÄ£»Èç¹û¿¼Âǵ½»·¾³±£»¤ºÍÉúÎï½µ½âµÄÒªÇó¶ø¶Ô×îµÍ±íÃæÕÅÁ¦µÄÒªÇóÊʵ±·ÅËÉ£¬¿ÉÑ¡ÓÃPFB-MC¡£ |
» ²ÂÄãϲ»¶
318Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
0703»¯Ñ§
ÒѾÓÐ13È˻ظ´
307·Ö²ÄÁÏרҵÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0855Çóµ÷¼Á²ÄÁÏ
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
¼×´¼/¶þÂÈ 1:15¹ýÖù×Ó
ÒѾÓÐ3È˻ظ´
272Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸Î÷±±Å©ÁÖÐóÄÁר˶336·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
pharmjackie
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 21
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2210
- Ìû×Ó: 312
- ÔÚÏß: 180.4Сʱ
- ³æºÅ: 302356
- ×¢²á: 2006-12-02
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
szxxck(½ð±Ò+50):лл£¡×¨ÓÐÃû´ÊÎÒÒѾ¸ÄÁË¡£ 2010-03-29 22:34
| A series of cation fluoride surfactant, N-[3-(dimethylamino)propyl]perfluoroalkylsulfonamides hydrochloride (CnF2n+1SO2NH(CH2)3NH(CH3)2+Cl¨C, n = 6, 8 (hereafter referred to as PFH-MC and PFO-MC respectively) had been synthesized. The surface tension curve had been plotted using volume-titration method at a pH of 2.6~2.7 at 25 ◦C for the compound alone and for the system with a salt concentration of 0.1mol/L. The influence the chain length of C-F moiety had on the surface activity of the aqueous solution was discussed with the above results. Comparison of the ability to form micelle, the ability to reduce surface tension, absorbtion state on the surface and the influence acidity had on the application of the surfactant showed that CMC decreased with increasing chain length, with a decreasing absorption capacity due to per-molecular increasing absorption area. The compound alone showed a minimum surface tension, (ycmc)PFH-MC, 15.02 mN/m, while a slight higher surface tension was observed for PFO-MC might be contributed to the solvate limitation that long-chain surfactant had and the steric influence. Additional salt can lower the CMC of the system, which can be explained by its ability to increasing solventphobic forces, but no significant effect had been observed for ycmc because excess hydrochloric acid in the solution might serve as electrolyte to shield capitular charge exclusion forces. The influences chain length had on salt effect was also discussed, which showed irregular alterations with PFH-MC exhibited the most strong salt effect. It might be due to a moderate chain length that PFH-MC had but PFO-MC and PFB-MC had a over-long or over-short chain, i.e. too strong or too weak hydrophobic forces could reduce the hydrophobic effect that additional salt might bring. We also studied how the surfactant¡¯s activity changed with pH. |
2Â¥2010-03-29 20:02:18
pharmjackie
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 21
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2210
- Ìû×Ó: 312
- ÔÚÏß: 180.4Сʱ
- ³æºÅ: 302356
- ×¢²á: 2006-12-02
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
3Â¥2010-03-29 20:04:20
pharmjackie
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 21
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 2210
- Ìû×Ó: 312
- ÔÚÏß: 180.4Сʱ
- ³æºÅ: 302356
- ×¢²á: 2006-12-02
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
szxxck(½ð±Ò+50, ·ÒëEPI+1):лл£¡ 2010-04-18 17:15
| The results showed that this series of perfluoroalkyl cationic fluoride surfacetant is applicable to strong acid conditions, resistant to salt and with high surfaceactivity. (´ËºóÒ»¾äÎÒ¸øÊ¡ÁË£¬Í¬Ç°Ò»¾ä»ù±¾ÊÇͬÒâ)¡£ Addition of salt could improve the surfactant¡¯s performance significantly, reducing the CMC of the surfactant. Taking the chain length influences into consideration, the six F-C numbered PFH-MC is the first choice with a comparable CMC with PFO-MC but a lower dose, and lower produce-cost than PFO-MC due to shorted C-F chain, while PFB-MC is the best choice when environment-protection and bio-degrade is taken into account. |
4Â¥2010-03-29 20:19:19














»Ø¸´´ËÂ¥